The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk StratificationMartin Miner*
Warren Alpert School of Medicine, Brown University, Providence, RI, USA
- *Corresponding Author:
- Martin Miner
Clinical Associate Professor of Family Medicine and Urology
Warren Alpert School of Medicine, Brown University
Men’s Health Center The Miriam Hospital
164 Summit Ave Providence, RI, USA
Tel: +1 508-672-5300
E-mail: [email protected]
Received date: April 24, 2014; Accepted date: May 26, 2014; Published date: June 02, 2014
Citation: Miner M (2014) The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk Stratification. J Diabetes Metab 5:386. doi: 10.4172/2155-6156.1000386
Copyright: © 2014 Martin M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This review discusses the latest evidence for the metabolic investigation of erectile dysfunction as it relates to cardiometabolic risk and visceral adiposity, the key component of metabolic syndrome. The authors illustrate this concept with a clinical example from their own practice, and the metabolic investigation of ED as it relates to the etiology and cardiovascular risk stratification utilizing the latest guidelines of cardiovascular risk released this past year. The authors conclude with the levels of evidence for the use of novel biomarkers in the evaluation of the patient with ED as applied to cardiometabolic risk.